News
SiSaf’s Innovative RNA Therapeutic for Rare Genetic Skeletal Disorders Begins the U.S. Regulatory Process for Orphan Drug Designation
Published October 12, 2022
CSSi LifeSciences Partners with DevLab Bio to Speed Commercialization of Therapeutic and Medical Device Technologies
Published June 21, 2022
BioCurity Pharmaceuticals Inc. ('BioCurity' or ‘Company’) Announces Presentation at ACRO Summit 2022 on Sensitizing Head and Neck Cancer to Radiation Using the Company’s Cerium Oxide Nanoparticles | Business Wire
Published March 10, 2021